ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2020 Updates on NSCLC: 1L Cemiplimab vs. Platinum-Doublet Chemo in Advanced Disease, Atezo + Bev for High PD-L1 Non-Sq Disease, 1L Nivo + Carboplatin/Paclitaxel/Bev for Advanced/Recurrent Non-Sq Disease
Login to view comments.
Click here to Login
